This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Viral Infections  • Neurology  • Neuromuscular diseases  • Dermatology  • Dermatologic Disorders  • Herpes  • Dermatology, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Michael Bigby, MD

Arch Dermatol. 2001;137:789-790.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Prevalence of Postherpetic Neuralgia After a First Episode of Herpes Zoster: Prospective Study With Long Term Follow Up
Helgason S, Petursson G, Gudmundsson, Sigurdsson JA
BMJ. 2000;321:794-796

Postherpetic neuralgia is one of the most dreaded complications of herpes zoster. Prevention of postherpetic neuralgia is therefore an objective of most studies of the treatment of herpes zoster. Therapeutic interventions have included antiviral agents, corticosteroids, tricyclic antidepressants, and combinations thereof. An accurate estimate of the frequency, duration, and clinical importance of postherpetic neuralgia after a single episode of herpes zoster would be helpful in interpreting studies of the prevention of postherpetic neuralgia and in counseling patients about the risk of long-term pain after acute episodes of herpes zoster.

The objective of this study was to estimate of the frequency, duration, and clinical importance of postherpetic neuralgia after a single episode of herpes zoster. The study was designed as . . . [Full Text of this Article]

Editors' Comment

Department of Dermatology
Harvard Medical School and Beth Israel Deaconess Medical Center
330 Brookline Ave
Boston, MA 02215

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?